Home › Medical Devices › Drug Delivery Devices
Drug Delivery Devices Market Research Reports & Consulting
Drug delivery technologies can be classified on the basis of the four delivery routes: oral, transdermal, inhalation, and parenteral. These innovative technologies are highly useful in protein and gene-based therapies. Upcoming drug delivery technologies are focusing on boosting sales volume through improved safety and efficacy. The market has a large number of suppliers offering products with multiple applications; but it still offers plentiful opportunities to new entrants wishing to tap niche market segments. see less
Drug delivery technologies can be classified on the basis of the four delivery routes: oral, transdermal, inhalation, and parenteral. These innovative technologies are highly useful in protein and gene-based therapies. Upcoming drug delivery technologies are focusing on boosting sales volume through ....see more
North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is primarily driven by the rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements. However, risk of needlestick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years.
|August 2016||$ 5650|
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021
The pen needles market is projected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% during the forecast period of 2016 to 2021. Growth in the pen needles market can be attributed to the favorable reimbursement environment and government support in selected countries; advantages of insulin pens over syringes and vials; technological advancements to minimize pain and anxiety; growing diabetic population; and conferences, meetings, and congresses that create pen needle awareness.
|June 2016||$ 5650|
Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Nasal (Drop), Topical (Solid), Implantable (Active), Transmucosal (Oral)), End User (Hospital, ASC, Home Care) -Forecast to 2020
The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.
|November 2015||$ 5650|
This report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications.
|November 2009||$ 5650|